— Know what they know.
Not Investment Advice

CLOV NASDAQ

Clover Health Investments, Corp.
1W: +3.1% 1M: +44.0% 3M: +78.2% YTD: +49.4% 1Y: -2.4% 3Y: +256.4% 5Y: -51.8%
$3.55
-0.05 (-1.39%)
 
Weekly Expected Move ±8.9%
$3 $3 $3 $4 $4
NASDAQ · Healthcare · Medical - Healthcare Plans · Alpha Radar Strong Buy · Power 65 · $1.8B mcap · 408M float · 1.54% daily turnover · Short 31% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
35.9 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: -21.1%  ·  5Y Avg: -54.1%
Cost Advantage ★
50
Intangibles
39
Switching Cost
29
Network Effect
19
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CLOV has No discernible competitive edge (35.9/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. Negative ROIC of -21.1% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$3
Avg Target
$3
High
Based on 1 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 1Hold: 5Sell: 3Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$3.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2025-10-21 Leerink Partners Whit Mayo Initiated $3 +2.7% $2.92
2024-12-17 Craig-Hallum Matt Hewitt Initiated $6 +89.9% $3.16
2024-08-06 Canaccord Genuity Richard Close Initiated $2 +34.3% $1.86
2022-11-16 Citigroup Initiated $2 +25.0% $1.44

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CLOV receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-18 C- D+
2026-05-06 D+ C-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

28 Grade D
Profitability
11
Balance Sheet
82
Earnings Quality
35
Growth
52
Value
29
Momentum
50
Safety
15
Cash Flow
50
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CLOV scores highest in Balance Sheet (82/100) and lowest in Profitability (11/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.46
Distress Zone
Piotroski F-Score
3/9
Beneish M-Score
-2.64
Unlikely Manipulator
Ohlson O-Score
-6.84
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
BBB+
Score: 62.2/100
Trend: Deteriorating
Earnings Quality
OCF/NI: -1.01x
Accruals: -20.4%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CLOV scores 0.46, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CLOV scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CLOV's score of -2.64 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CLOV's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CLOV receives an estimated rating of BBB+ (score: 62.2/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-32.60x
PEG
0.42x
P/S
0.83x
P/B
5.47x
P/FCF
17.18x
P/OCF
16.37x
EV/EBITDA
-15.25x
EV/Revenue
0.38x
EV/EBIT
-14.78x
EV/FCF
15.43x
Earnings Yield
-6.08%
FCF Yield
5.82%
Shareholder Yield
3.32%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CLOV currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
-0.026
EBIT / Rev
×
Asset Turnover
3.942
Rev / Assets
×
Equity Multiplier
1.726
Assets / Equity
=
ROE
-17.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CLOV's ROE of -17.5% is driven by Asset Turnover (3.942), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1494 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$3.55
Median 1Y
$2.14
5th Pctile
$0.54
95th Pctile
$8.60
Ann. Volatility
81.2%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Peter Kuipers, Financial
ancial Officer
$525,000 $1,175,929 $4,090,134
Jamie L. Reynoso,
Chief Executive Officer of Medicare Advantage
$550,001 $— $2,936,332
Andrew Toy, Co-Founder
and Chief Executive Officer
$800,000 $— $2,638,770
Conrad Wai, Counterpart
tive Officer of Counterpart Health
$495,000 $— $2,423,876
Brady Priest, Clover
Executive Officer of Clover Care Services
$495,000 $— $2,398,922

CEO Pay Ratio

12:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $2,936,332
Avg Employee Cost (SGA/emp): $243,541
Employees: 724

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
724
+27.0% YoY
Revenue / Employee
$2,657,884
Rev: $1,924,308,000
Profit / Employee
$-118,162
NI: $-85,549,000
SGA / Employee
$243,541
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 1.6% 1.7% 14.4% 15.1% 9.8% 10.8% -76.1% -75.4% -58.5% -50.9% -66.3% -49.7% -38.5% -28.4% -13.7% -8.0% -13.7% -18.6% -26.3% -17.5% -17.52%
ROA -3.6% -3.9% -96.5% -1.0% -65.9% -72.7% -38.6% -38.3% -29.7% -25.8% -30.9% -23.2% -17.9% -13.3% -7.5% -4.4% -7.5% -10.1% -15.3% -10.2% -10.15%
ROIC 53.6% 71.1% 9.7% 9.2% 8.0% 6.9% -10.5% -10.3% -8.2% -7.0% -3.0% -2.2% -1.7% -1.3% -30.2% -16.1% -27.8% -38.1% -31.7% -21.1% -21.08%
ROCE -4.2% -4.8% -98.7% -1.1% -69.2% -76.3% -89.6% -90.4% -70.5% -59.5% -68.1% -50.2% -38.5% -30.5% -12.4% -6.6% -11.5% -15.7% -25.8% -17.1% -17.14%
Gross Margin -11.2% -2.1% -2.3% 1.4% -1.4% 2.0% 0.6% 14.7% 23.7% 23.0% 12.2% 23.6% 30.3% 24.5% 27.9% 23.6% 20.9% 14.7% 15.2% 21.3% 21.30%
Operating Margin -44.1% -34.9% -43.2% -10.0% -12.1% -8.6% -11.9% -24.8% -9.0% -11.0% -12.9% -6.5% 2.0% -2.7% -6.4% -0.3% -2.2% -4.9% -10.1% 3.6% 3.65%
Net Margin -77.0% -8.1% -43.3% -8.6% -12.3% -8.8% -9.4% -22.5% -9.0% -13.6% -13.8% -5.5% 2.1% -2.8% -6.6% -0.3% -2.2% -4.9% -10.1% 3.6% 3.65%
EBITDA Margin -76.7% -8.0% -43.0% -8.5% -12.2% -8.7% -9.4% -24.1% -8.7% -10.8% -13.7% -6.4% 2.1% -2.6% -6.3% -0.2% -2.1% -4.8% -10.0% 3.7% 3.72%
FCF Margin -26.6% -21.8% -19.2% -11.5% -8.6% -2.5% -6.0% -2.5% 0.8% -5.5% -10.0% -13.4% -13.6% -9.0% 2.4% -0.6% -3.0% -4.9% -3.6% 2.5% 2.47%
OCF Margin -26.5% -21.7% -19.2% -11.5% -8.6% -2.5% -5.9% -2.3% 1.0% -5.2% -9.9% -13.3% -13.6% -8.9% 2.5% -0.5% -2.9% -4.8% -3.5% 2.6% 2.59%
ROE 3Y Avg snapshot only -27.22%
ROE 5Y Avg snapshot only -58.15%
ROA 3Y Avg snapshot only -14.29%
ROIC 3Y Avg snapshot only -22.50%
ROIC Economic snapshot only -17.00%
Cash ROA snapshot only 10.58%
Cash ROIC snapshot only 26.83%
CROIC snapshot only 25.56%
NOPAT Margin snapshot only -2.03%
Pretax Margin snapshot only -2.58%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 3.01%
SBC / Revenue snapshot only 4.05%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -11.34 -5.90 -2.98 -2.73 -2.54 -1.84 -1.31 -1.20 -1.65 -2.29 -2.15 -2.82 -4.92 -15.13 -36.02 -71.06 -32.94 -26.90 -14.21 -16.46 -32.602
P/S Ratio 5.74 2.58 1.19 0.78 0.39 0.27 0.13 0.14 0.18 0.28 0.31 0.30 0.40 0.90 1.13 1.20 0.88 0.88 0.63 0.42 0.833
P/B Ratio -8.81 -5.04 3.27 3.14 1.90 1.52 1.24 1.13 1.20 1.45 1.60 1.57 2.13 4.83 4.54 5.23 4.16 4.60 3.94 3.04 5.469
P/FCF -21.57 -11.84 -6.19 -6.79 -4.58 -10.75 -2.13 -5.59 21.76 -5.16 -3.16 -2.27 -2.94 -9.99 46.54 -205.60 -29.46 -18.16 -17.62 17.18 17.183
P/OCF 17.55 44.47 16.37 16.369
EV/EBITDA -12.66 -6.39 -2.04 -1.79 -1.09 -0.51 -0.34 -0.22 -0.38 -0.85 -1.09 -1.43 -3.22 -12.40 -30.10 -68.28 -29.53 -24.02 -13.36 -15.25 -15.249
EV/Revenue 5.78 2.61 0.79 0.51 0.17 0.07 0.03 0.03 0.04 0.10 0.16 0.15 0.25 0.75 0.97 1.05 0.75 0.76 0.58 0.38 0.381
EV/EBIT -12.65 -6.38 -2.04 -1.78 -1.08 -0.51 -0.34 -0.22 -0.38 -0.85 -1.08 -1.41 -3.17 -12.19 -29.22 -64.13 -28.45 -23.35 -13.09 -14.78 -14.785
EV/FCF -21.74 -12.00 -4.11 -4.42 -1.94 -2.97 -0.55 -1.05 5.11 -1.89 -1.56 -1.10 -1.82 -8.32 39.89 -180.08 -24.86 -15.60 -16.24 15.43 15.435
Earnings Yield -8.8% -17.0% -33.6% -36.6% -39.4% -54.5% -76.4% -83.2% -60.7% -43.7% -46.5% -35.5% -20.3% -6.6% -2.8% -1.4% -3.0% -3.7% -7.0% -6.1% -6.08%
FCF Yield -4.6% -8.4% -16.2% -14.7% -21.8% -9.3% -46.9% -17.9% 4.6% -19.4% -31.7% -44.1% -34.0% -10.0% 2.1% -0.5% -3.4% -5.5% -5.7% 5.8% 5.82%
PEG Ratio snapshot only 0.419
Price/Tangible Book snapshot only 3.066
EV/OCF snapshot only 14.704
EV/Gross Profit snapshot only 2.071
Shareholder Yield snapshot only 3.32%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.16 1.16 2.02 2.02 2.02 2.02 1.45 1.45 1.45 1.45 1.64 1.64 1.64 1.64 1.61 1.61 1.61 1.61 1.47 1.47 1.474
Quick Ratio 1.16 1.16 2.02 2.02 2.02 2.02 1.45 1.45 1.45 1.45 1.64 1.64 1.64 1.64 1.61 1.61 1.61 1.61 1.47 1.47 1.474
Debt/Equity -0.22 -0.22 0.05 0.05 0.05 0.05 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Net Debt/Equity -1.10 -1.10 -1.10 -1.10 -0.92 -0.92 -0.92 -0.92 -0.81 -0.81 -0.81 -0.81 -0.65 -0.65 -0.65 -0.65 -0.31 -0.31 -0.309
Debt/Assets 0.52 0.52 0.03 0.03 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Debt/EBITDA -0.32 -0.28 -0.05 -0.05 -0.07 -0.06 -0.02 -0.02 -0.02 -0.03 -0.02 -0.03 -0.04 -0.05 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00 -0.000
Net Debt/EBITDA -0.10 -0.08 1.03 0.96 1.48 1.34 0.98 0.97 1.24 1.47 1.11 1.52 1.97 2.50 5.02 9.68 5.46 3.95 1.14 1.73 1.727
Interest Coverage -9.35 -14.91 -33.76 -247.12 -242.53 -269.50 -248.00 -355.03 -475.41 -1536.27 -30123.00 -22188.57
Equity Multiplier -0.43 -0.43 1.78 1.78 1.78 1.78 2.27 2.27 2.27 2.27 1.99 1.99 1.99 1.99 1.70 1.70 1.70 1.70 1.75 1.75 1.753
Cash Ratio snapshot only 0.457
Defensive Interval snapshot only 200.1 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 7.09 9.02 2.42 3.52 4.24 4.94 3.95 3.32 2.73 2.10 2.11 2.15 2.20 2.24 2.38 2.58 2.79 3.08 3.43 3.94 3.942
Inventory Turnover
Receivables Turnover 22.32 28.40 15.15 22.08 26.55 30.97 25.11 21.12 17.31 13.34 11.49 11.69 11.97 12.17 15.32 16.61 17.96 19.81 15.30 17.58 17.582
Payables Turnover 65.03 84.04 52.76 74.77 88.39 102.11 114.04 94.66 74.37 54.43 34.55 34.27 34.39 34.79 28.05 30.51 34.13 38.97 16.70 19.22 19.217
DSO 16 13 24 17 14 12 15 17 21 27 32 31 30 30 24 22 20 18 24 21 20.8 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 6 4 7 5 4 4 3 4 5 7 11 11 11 10 13 12 11 9 22 19 19.0 days
Cash Conversion Cycle 11 9 17 12 10 8 11 13 16 21 21 21 20 19 11 10 10 9 2 2 1.8 days
Fixed Asset Turnover snapshot only 346.306
Cash Velocity snapshot only 23.190
Capital Intensity snapshot only 0.245
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 4.5% 2.5% 1.9% 2.0% 1.7% 1.5% 1.4% 36.3% -7.1% -38.6% -58.1% -49.3% -36.6% -16.4% -6.0% 0.2% 5.8% 14.8% 40.3% 48.7% 48.75%
Net Income -89.8% -30.0% -4.4% -2.9% 16.3% 16.0% 42.3% 45.3% 35.0% 48.7% 37.1% 52.5% 52.6% 59.7% 79.8% 84.3% 65.2% 36.2% -98.9% -1.3% -1.27%
EPS -88.9% -28.9% -3.7% -2.1% 28.2% 26.0% 43.1% 45.9% 35.4% 49.0% 37.6% 59.9% 54.1% 60.5% 80.3% 82.1% 66.1% 39.0% -89.2% -1.1% -1.12%
FCF -20.4% -11.0% -2.5% -41.5% 11.8% 71.2% 26.4% 70.7% 1.1% -33.2% 30.3% -1.7% -11.5% -37.5% 1.2% 95.6% 76.7% 37.6% -3.1% 7.3% 7.28%
EBITDA -24.0% -11.9% -7.9% -5.3% 8.1% 11.2% 40.9% 44.3% 33.4% 49.0% 38.1% 55.1% 55.7% 58.5% 78.8% 85.0% 65.4% 39.5% -90.1% -1.4% -1.41%
Op. Income -17.8% -334.7% -8.6% -2.3% -34.9% 12.9% 41.7% 39.9% 44.9% 44.7% 44.0% 58.5% 60.4% 63.9% 78.0% 83.9% 63.4% 35.9% -87.0% -1.3% -1.34%
OCF Growth snapshot only 8.75%
Asset Growth snapshot only -6.84%
Equity Growth snapshot only -9.51%
Shares Change snapshot only 7.13%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.4% 75.6% 42.2% 28.0% 17.0% 8.6% -2.3% -11.5% -14.6% -16.2% -17.9% -8.9% -8.90%
Revenue 5Y 56.4% 39.1% 30.6% 25.6% 25.59%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y 40.2% 37.1% 59.0% 80.3% 2.6% 1.5% 92.2% 92.18%
Gross Profit 5Y 48.7% 37.3% 41.1% 52.4% 52.35%
Op. Income 3Y
Op. Income 5Y
FCF 3Y 14.9%
FCF 5Y
OCF 3Y 22.8%
OCF 5Y
Assets 3Y 19.0% 19.0% 28.8% 28.8% 28.8% 28.8% -15.2% -15.2% -15.2% -15.2% -12.5% -12.5% -12.54%
Assets 5Y 4.7% 4.7% 15.1% 15.1% 15.15%
Equity 3Y -14.0% -14.0% -14.0% -14.0% -4.7% -4.7% -4.72%
Book Value 3Y -15.2% -15.4% -15.8% -16.0% -7.2% -8.0% -8.04%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.96 0.96 0.96 0.97 0.85 0.53 0.25 0.18 0.07 0.00 0.09 0.42 0.20 0.14 0.05 0.17 0.165
Earnings Stability 0.61 0.62 0.23 0.15 0.19 0.12 0.00 0.03 0.00 0.00 0.14 0.25 0.07 0.08 0.24 0.35 0.353
Margin Stability 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20 0.37 0.37 0.32 0.322
Rev. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.83 0.82 0.86 0.81 0.85 0.50 0.50 0.50 0.50 0.50 0.50 0.86 0.50 0.50 0.500
Earnings Smoothness
ROE Trend 0.28 0.49 0.31 0.41 0.72 0.68 0.46 0.31 0.16 0.13 0.132
Gross Margin Trend -0.13 -0.08 -0.03 -0.00 0.09 0.14 0.20 0.20 0.19 0.16 0.18 0.16 0.10 0.05 -0.04 -0.05 -0.046
FCF Margin Trend 0.01 0.12 0.12 0.16 0.18 0.07 0.03 -0.06 -0.10 -0.05 0.10 0.07 0.03 0.02 0.00 0.09 0.095
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.52 0.50 0.48 0.40 0.55 0.17 0.60 0.20 -0.09 0.42 0.68 1.24 1.67 1.50 -0.81 0.29 1.08 1.45 0.78 -1.01 -1.005
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.01 1.02 1.07 0.81 1.05 1.00 1.00 1.00 1.01 0.96 1.18 1.03 1.02 1.03 0.95 0.953
FCF/Net Income snapshot only -0.958
CapEx/Revenue 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.2% 0.2% 0.3% 0.0% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.12%
CapEx/Depreciation snapshot only 1.563
Accruals Ratio -1.71 -1.98 -0.50 -0.60 -0.30 -0.60 -0.15 -0.31 -0.32 -0.15 -0.10 0.05 0.12 0.07 -0.14 -0.03 0.01 0.05 -0.03 -0.20 -0.204
Sloan Accruals snapshot only -0.058
Cash Flow Adequacy snapshot only 21.111
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.4% 0.6% 0.8% 1.4% 0.8% 0.9% 1.0% 1.4% 1.5% 1.5% 0.9% 1.2% 2.6% 3.7% 3.4% 4.5% 3.3% 3.32%
Net Buyback Yield -0.1% -0.2% -16.5% -16.8% -27.8% -34.4% 1.1% 0.4% 0.5% 0.8% 1.1% 1.4% 1.5% 0.9% 1.1% 2.6% 3.5% 3.2% 4.4% 3.1% 3.15%
Total Shareholder Return -0.1% -0.2% -16.5% -16.8% -27.8% -34.4% 1.1% 0.4% 0.5% 0.8% 1.1% 1.4% 1.5% 0.9% 1.1% 2.6% 3.5% 3.2% 4.4% 3.1% 3.15%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.98 0.97 1.00 1.00 1.02 1.03 0.96 0.93 1.03 1.02 1.01 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.11 1.07 1.03 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.01 1.01 1.01 1.02 1.00 1.00 1.00 1.00 1.00 1.000
EBIT Margin -0.46 -0.41 -0.39 -0.29 -0.15 -0.15 -0.10 -0.12 -0.11 -0.12 -0.14 -0.10 -0.08 -0.06 -0.03 -0.02 -0.03 -0.03 -0.04 -0.03 -0.026
Asset Turnover 7.09 9.02 2.42 3.52 4.24 4.94 3.95 3.32 2.73 2.10 2.11 2.15 2.20 2.24 2.38 2.58 2.79 3.08 3.43 3.94 3.942
Equity Multiplier -0.43 -0.43 -14.91 -14.91 -14.91 -14.91 1.97 1.97 1.97 1.97 2.14 2.14 2.14 2.14 1.83 1.83 1.83 1.83 1.73 1.73 1.726
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.17 $-1.25 $-1.25 $-1.30 $-0.84 $-0.93 $-0.71 $-0.70 $-0.54 $-0.47 $-0.44 $-0.28 $-0.25 $-0.19 $-0.09 $-0.05 $-0.08 $-0.11 $-0.17 $-0.11 $-0.11
Book Value/Share $-1.51 $-1.47 $1.14 $1.13 $1.12 $1.12 $0.75 $0.75 $0.74 $0.74 $0.59 $0.50 $0.58 $0.58 $0.69 $0.69 $0.67 $0.67 $0.60 $0.58 $0.65
Tangible Book/Share $-1.52 $-1.48 $1.13 $1.12 $1.12 $1.11 $0.70 $0.70 $0.70 $0.70 $0.59 $0.50 $0.57 $0.58 $0.69 $0.68 $0.66 $0.66 $0.59 $0.57 $0.57
Revenue/Share $2.32 $2.87 $3.13 $4.54 $5.42 $6.30 $7.27 $6.11 $5.00 $3.84 $3.03 $2.61 $3.07 $3.15 $2.79 $2.99 $3.16 $3.46 $3.72 $4.15 $4.23
FCF/Share $-0.62 $-0.62 $-0.60 $-0.52 $-0.47 $-0.16 $-0.44 $-0.15 $0.04 $-0.21 $-0.30 $-0.35 $-0.42 $-0.28 $0.07 $-0.02 $-0.09 $-0.17 $-0.13 $0.10 $0.04
OCF/Share $-0.62 $-0.62 $-0.60 $-0.52 $-0.47 $-0.16 $-0.43 $-0.14 $0.05 $-0.20 $-0.30 $-0.35 $-0.42 $-0.28 $0.07 $-0.01 $-0.09 $-0.17 $-0.13 $0.11 $0.05
Cash/Share $0.24 $0.23 $1.31 $1.30 $1.29 $1.29 $0.70 $0.70 $0.70 $0.70 $0.49 $0.42 $0.48 $0.48 $0.45 $0.45 $0.44 $0.43 $0.18 $0.18 $0.34
EBITDA/Share $-1.06 $-1.17 $-1.21 $-1.29 $-0.84 $-0.92 $-0.70 $-0.71 $-0.55 $-0.46 $-0.43 $-0.27 $-0.24 $-0.19 $-0.09 $-0.05 $-0.08 $-0.11 $-0.16 $-0.10 $-0.10
Debt/Share $0.34 $0.33 $0.06 $0.06 $0.06 $0.06 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Net Debt/Share $0.10 $0.10 $-1.25 $-1.24 $-1.23 $-1.23 $-0.69 $-0.69 $-0.69 $-0.68 $-0.48 $-0.41 $-0.47 $-0.47 $-0.45 $-0.45 $-0.44 $-0.43 $-0.18 $-0.18 $-0.18
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.458
Altman Z-Prime snapshot only -9.059
Piotroski F-Score 3 3 5 5 6 6 4 4 5 3 4 3 3 3 4 3 2 2 2 3 3
Beneish M-Score -7.20 -9.79 -1.49 -4.76 1.06 -4.58 -5.10 -2.49 -2.70 -1.54 -4.20 -2.83 -2.38 -2.60 -2.96 -2.20 -1.79 -1.41 -1.32 -2.64 -2.640
Ohlson O-Score snapshot only -6.840
ROIC (Greenblatt) snapshot only -54.02%
Net-Net WC snapshot only $0.14
EVA snapshot only $-66303190.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB+
Credit Score 18.84 20.00 31.87 31.12 31.23 34.25 29.00 25.89 37.20 25.15 28.77 28.19 36.19 41.16 65.38 76.27 65.31 71.42 62.06 62.16 62.164
Credit Grade snapshot only 8
Credit Trend snapshot only -14.110
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 60
Sector Credit Rank snapshot only 53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms